Predictors | ICCa | Explained variance (%)b | Intercept | Slopec | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BAFF | anti-Jo-1 | CK | BAFF (ng/ml) | p | anti- Jo-1 (kU/l) | p | CK (μkat/l) | p | BAFF (ng/ml) | p | anti- Jo-1 (kU/l) | p | CK (μkat/l) | p | ||
Time from diagnosisd,e | – | 0 | 62.3 | 31.2 | 1.85 | ˂ 0.001 | 340.9 | 0.04 | 9.06 | 0.04 | 0.01 | 0.10 | 11.9 | 0.21 | −0.06 | 0.63 |
BAFFe (ng/ml) | 0.030 | – | 79.1 | 49.6 | – | – | 748.0 | 0.03 | 0 | 0.99 | – | – | 91.6 | 0.22 | 4.34 | 0.003 |
anti-Jo-1e (kU/l) | 0.678 | 31.6 | – | 72.3 | 2.33 | ˂ 0.001 | – | – | 1.4 | 0.34 | 0.002 | 0.03 | – | – | 0.02 | 0.05 |
CKe (μkat/l) | 0.100 | 75.6 | 73.8 | – | 2.30 | ˂ 0.001 | 747.1 | 0.03 | – | – | 0.14 | 0.02 | 7.14 | 0.59 | – | – |
CRPf (mg/l) | 0.107 | 74.3 | 70.2 | 44.1 | 2.35 | ˂ 0.001 | 749.5 | 0.03 | 8.7 | 0.02 | 0.15 | 0.08 | − 21.7 | 0.76 | 0.98 | 0.07 |
Pulmonary VASg (mm) | 0.582 | 61.7 | 60.4 | ND | 2.32 | ˂ 0.001 | 785.8 | 0.03 | ND | – | 0.11 | 0.16 | −16.5 | 0.03 | ND | – |
Muscle VASg (mm) | 0.319 | 84.5 | 71.9 | ND | 2.32 | ˂ 0.001 | 784.4 | 0.03 | ND | – | −0.12 | 0.54 | −7.8 | 0.22 | ND | – |
Global VASg (mm) | 0.241 | 28.3 | 71.2 | ND | 1.30 | ˂ 0.001 | 939.3 | 0.07 | ND | – | 0.06 | 0.01 | −7.4 | 0.21 | ND | – |